Methyl chavicol and its synthetic analogue as possible antioxidant and antilipase agents based on the in vitro and in silico assays

Oxidative Medicine and Cellular Longevity

Volumn 2018, Issue , 2018, Pages

  Santos, Bruna Celeida Silva ^a   Pires, Andressa Soares ^a   Yamamoto, Célia Hitomi ^a   Couri, Mara Rubia Costa ^a   Taranto, Alex Gutterres ^b   Alves, Maria Silvana ^a   De Matos Araújo, Ana Lúcia Dos Santos ^a   De Sousa, Orlando Vieira ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO JOÃO DEL REI   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ANTIOXIDANT; BETA CAROTENE; ESTRAGOLE; FREE RADICAL; LINOLEIC ACID; MALONALDEHYDE; THIOBARBITURIC ACID; TRIACYLGLYCEROL LIPASE; ANISOLE DERIVATIVE; ENZYME INHIBITOR; EPOXIDE;

ANTIOXIDANT ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; COLORIMETRY; COMPUTER MODEL; CONTROLLED STUDY; IN VITRO STUDY; LIPID METABOLISM; LIPID PEROXIDATION; LIVER CELL; MASS FRAGMENTOGRAPHY; MOLECULAR DOCKING; MOLECULAR INTERACTION; OXIDATION; OXIDATIVE STRESS; PROTON NUCLEAR MAGNETIC RESONANCE; SYNTHESIS; THIN LAYER CHROMATOGRAPHY; ANTAGONISTS AND INHIBITORS; CHEMISTRY; KINETICS;

ANISOLES; ANTIOXIDANTS; ENZYME INHIBITORS; EPOXY COMPOUNDS; KINETICS; LIPASE; MOLECULAR DOCKING SIMULATION;

EID: 85054726806     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2018/2189348     Document Type: Article

References (50)

1. V. Sosa, T. Moliné, R. Somoza, R. Paciucci, H. Kondoh, and M. E. Lleonart, "Oxidative stress and cancer: an overview," Ageing Research Reviews, vol. 12, no. 1, pp. 376-390, 2013.
2. M. Valko, D. Leibfritz, J. Moncol, M. T. D. Cronin, M. Mazur, and J. Telser, "Free radicals and antioxidants in normal physiological functions and human disease," The International Journal of Biochemistry & Cell Biology, vol. 39, no. 1, pp. 44-84, 2007.
3. P. X. Picon, C. M. Zanatta, F. Gerchman, T. Zelmanovitz, J. L. Gross, and L. H. Canani, "Análise dos critérios de definição da Sídrome Metabólica em Pacientes com Diabetes Metilo tipo 2," Arquivos Brasileiros Endocrinologia & Metabologia, vol. 50, no. 2, pp. 264-270, 2006.
4. M. P. Mattson, "Dietary factors, hormesis and health," Ageing Research Reviews, vol. 7, no. 1, pp. 43-48, 2008.
5. L. Li, G. Ishdorj, and S. B. Gibson, "Reactive oxygen species regulation of autophagy in cancer: implications for cancer treatment," Free Radical Biology & Medicine, vol. 53, no. 7, pp. 1399-1410, 2012.
6. L. M. Magalhães, M. A. Segundo, S. Reis, and J. L. F. C. Lima, "Methodological aspects about in vitro evaluation of antioxidant properties," Analytica Chimica Acta, vol. 613, no. 1, pp. 1-19, 2008.
7. J. P. Paula, P. V. Farago, J. L. C. Ribas et al., "In vivo evaluation of the mutagenic potencial of estragole and eugenol chemotypes of Ocimum selloi Benth. essential oil," Latin American Journal of Pharmacy, vol. 26, no. 6, pp. 846-851, 2007.
8. J. P. de Paula, M. R. Gomes-Carneiro, and F. J. R. Paumgartten, "Chemical composition, toxicity and mosquito repellency of Ocimum selloi oil," Journal of Ethnopharmacology, vol. 88, no. 2-3, pp. 253-260, 2003.
9. + channels," Brazilian Journal of Medical and Biological Research, vol. 46, no. 12, pp. 1056-1063, 2013.
10. F. M. de Souza Silva-Comar, L. A. M. Wiirzler, S. E. Silva-Filho et al., "Effect of estragole on leukocyte behavior and phagocytic activity of macrophages," Evidence-based Complementary and Alternative Medicine, vol. 2014, Article ID 784689, 7 pages, 2014.
11. S. Pattnaik, V. R. Subramanyam, M. Bapaji, and C. R. Kole, "Antibacterial and antifungal activity of aromatic constituents of essential oils," Microbios, vol. 89, no. 358, pp. 39-46, 1997.
12. N. R. Drinkwater, E. C. Miller, J. A. Miller, and H. C. Pitot, "Hepatocarcinogenicity of estragole (1-allyl-4-methoxybenzene) and 1′-hydroxyestragole in the mouse and mutagenicity of 1′-acetoxyestragole in bacteria," Journal of the National Cancer Institute, vol. 57, no. 6, pp. 1323-1331, 1976.
13. E. C. Miller, A. B. Swanson, D. H. Phillips, T. L. Fletcher, A. Liem, and J. A. Miller, "Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole," Cancer Research, vol. 43, no. 3, pp. 1124-1134, 1983.
14. R. W. Wiseman, T. R. Fennell, J. A. Miller, and E. C. Miller, "Further characterization of the DNA adducts formed by electrophilic esters of the hepatocarcinogens 1′-hydroxysafrole and 1′-hydroxyestragole in vitro and in mouse liver in vivo, including new adducts at C-8 and N-7 of guanine residues," Cancer Research, vol. 45, no. 7, pp. 3096-3105, 1985.
15. S. M. F. Jeurissen, A. Punt, M. G. Boersma et al., "Human cytochrome P450 enzyme specificity for the bioactivation of estragole and related alkenylbenzenes," Chemical Research in Toxicology, vol. 20, no. 5, pp. 798-806, 2007.
16. A. Anthony, J. Caldwell, A. J. Hutt, and R. L. Smith, "Metabolism of estragole in rat and mouse and influence of dose size on excretion of the proximate carcinogen 1′-hydroxyestragole," Food and Chemical Toxicology, vol. 25, no. 11, pp. 799-806, 1987.
17. T. M. Guenthner and G. Luo, "Investigation of the role of the 2′,3′-epoxidation pathway in the bioactivation and genotoxicity of dietary allylbenzene analogs," Toxicology, vol. 160, no. 1-3, pp. 47-58, 2001.
18. G. Luo, M. K. Qato, and T. M. Guenthner, "Hydrolysis of the 2 ′,3′-allylic epoxides of allylbenzene, estragole, eugenol, and safrole by both microsomal and cytosolic epoxide hydrolases," Drug Metabolism and Disposition, vol. 20, no. 3, pp. 440-445, 1992.
19. D. H. Phillips, J. A. Miller, E. C. Miller, and B. Adams, "Structures of the DNA adducts formed in mouse liver after administration of the proximate hepatocarcinogen 1′-hydroxyestragole," Cancer Research, vol. 41, no. 1, pp. 176-186, 1981.
20. 14C]-labeled trans-anethole, estragole and p-propylanisole in human volunteers," Xenobiotica, vol. 17, no. 10, pp. 1223-1232, 1987.
21. E. Solheim and R. R. Scheline, "Metabolism of alkenebenzene derivatives in the rat I. p-Methoxyallylbenzene (estragole) and p-methoxypropenylbenzene (anethole)," Xenobiotica, vol. 3, no. 8, pp. 493-510, 1973.
22. 32P-Postlabelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturallyoccurring alkenylbenzenes. II. Newborn male B6C3F1 mice," Carcinogenesis, vol. 5, no. 12, pp. 1623-1628, 1984.
23. 32P-Post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice," Carcinogenesis, vol. 5, no. 12, pp. 1613-1622, 1984.
24. L. L. Mensor, F. S. Menezes, G. G. Leitão et al., "Screening of Brazilian plant extracts for antioxidant activity by the use of DPPH free radical method," Phytotherapy Research, vol. 15, no. 2, pp. 127-130, 2001.
25. K. Mishra, H. Ojha, and N. K. Chaudhury, "Estimation of antiradical properties of antioxidants using DPPH assay: a critical review and results," Food Chemistry, vol. 130, no. 4, pp. 1036-1043, 2012.
26. I. I. Koleva, T. A. van Beek, J. P. H. Linssen, A. de Groot, and L. N. Evstatieva, "Screening of plant extracts for antioxidant activity: a comparative study on three testing methods," Phytochemical Analysis, vol. 13, no. 1, pp. 8-17, 2002.
27. A. Zeb and F. Ullah, "A simple spectrophotometric method for the determination of thiobarbituric acid reactive substances in fried fast foods," Journal of Analytical Methods in Chemistry, vol. 2016, Article ID 9412767, 5 pages, 2016.
28. J. A. Buege and S. D. Aust, "[30] Microsomal lipid peroxidation," Methods in Enzymology, vol. 52, pp. 302-310, 1978.
29. S. P. de Souza, L. L. S. Pereira, A. A. Souza, and C. D. dos Santos, "Inhibition of pancreatic lipase by extracts of Baccharis trimera (Less.) DC., Asteraceae: evaluation of antinutrients and effect on glycosidases," Revista Brasileira de Farmacognosia, vol. 21, no. 3, pp. 450-455, 2011.
30. S. L. Mayo, B. D. Olafson, and W. A. Goddard, "DREIDING: a generic force field for molecular simulations," The Journal of Physical Chemistry, vol. 94, no. 26, pp. 8897-8909, 1990.
31. J. J. P. Stewart, "Optimization of parameters for semiempirical methods VI: more modifications to the NDDO approximations and re-optimization of parameters," Journal of Molecular Modeling, vol. 19, no. 1, pp. 1-32, 2013.
32. H. Van Tilbeurgh, M. P. Egloff, C. Martinez, N. Rugani, R. Verger, and C. Cambillau, "Interfacial activation of the lipase-procolipase complex by mixed micelles revealed by X-ray crystallography," Nature, vol. 362, no. 6423, pp. 814-820, 1993.
33. E. H. B. Maia, V. A. Campos, B. dos Reis Santos et al., "Octopus: a platform for the virtual high-throughput screening of a pool of compounds against a set of molecular targets," Journal of Molecular Modeling, vol. 23, no. 1, p. 26, 2017.
34. O. Trott and A. J. Olson, "AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading," Journal of Computational Chemistry, vol. 31, no. 2, pp. 455-461, 2010.
35. M. E. de Oliveira, G. Cenzi, R. R. Nunes et al., "Antimalarial activity of 4-metoxychalcones: docking studies as falcipain/plasmepsin inhibitors, ADMET and lipophilic efficiency analysis to identify a putative oral lead candidate," Molecules, vol. 18, no. 12, pp. 15276-15287, 2013.
36. G. M. Morris, R. Huey, W. Lindstrom et al., "AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility," Journal of Computational Chemistry, vol. 30, no. 16, pp. 2785-2791, 2009.
37. M. C. Santos Junior, S. A. Assis, A. Góes-Neto et al., "Structure-based drug design studies of UDP-N-acetylglucosamine pyrophosphosrylase, a key enzyme for the control of witches' broom disease," Chemistry Central Journal, vol. 7, pp. 1-7, 2013.
38. M. L. A. Von Holleben and C. M. Schuch, "Ativação do peróxido de hidrogênio para a epoxidação de olefinas não funcionalizadas," Química Nova, vol. 20, no. 1, pp. 58-71, 1996.
39. D. Amic, D. Davidovic-Amic, D. Beslo, V. Rastija, B. Lucic, and N. Trinajstic, "SAR and QSAR of the antioxidant activity of flavonoids," Current Medicinal Chemistry, vol. 14, no. 7, pp. 827-845, 2007.
40. J. Olivero-Verbel, T. González-Cervera, J. Güette-Fernandez, B. Jaramillo-Colorado, and E. Stashenko, "Chemical composition and antioxidant activity of essential oils isolated from Colombian plants," Brazilian Journal of Pharmacognosy, vol. 20, no. 4, pp. 568-574, 2010.
41. H. Li, Y. Ge, Z. Luo et al., "Evaluation of the chemical composition, antioxidant and anti-inflammatory activities of distillate and residue fractions of sweet basil essential oil," Journal of Food Science and Technology, vol. 54, no. 7, pp. 1882-1890, 2017.
42. H. J. Damien Dorman, S. G. Deans, R. C. Noble, and P. Surai, "Evaluation in vitro of plant essential oils as natural antioxidants," Journal of Essential Oil Research, vol. 7, no. 6, pp. 645-651, 1995.
43. A. M. Pisoschi and A. Pop, "The role of antioxidants in the chemistry of oxidative stress: a review," European Journal of Medicinal Chemistry, vol. 97, pp. 55-74, 2015.
44. E. S. Lima and D. S. P. Abdalla, "Peroxidação lipídica: mecanismos e avaliação em amostras biológicas," Revista Brasileira de Ciências Farmacêuticas, vol. 37, no. 3, pp. 293-303, 2010.
45. J. M. Duarte-Almeida, R. J. dos Santos, M. I. Genovese, and F. M. Lajolo, "Avaliação da atividade antioxidante utilizando sistema β-caroteno/ácido linoleico e método de seqüestro de radicais DPPH," Ciência e Tecnologia de Alimentos, vol. 26, no. 2, pp. 446-452, 2006.
46. Y. Teng and Y. Xu, "A modified para-nitrophenyl palmitate assay for lipase synthetic activity determination in organic solvent," Analytical Biochemistry, vol. 363, no. 2, pp. 297-299, 2007.
47. M. E. Lowe, "The catalytic site residues and interfacial binding of human pancreatic lipase," The Journal of Biological Chemistry, vol. 267, no. 24, pp. 17069-17073, 1992.
48. G. K. Veeramachaneni, K. K. Raj, L. M. Chalasani, S. K. Annamraju, J. S. Bondili, and V. R. Talluri, "Shape based virtual screening and molecular docking towards designing novel pancreatic lipase inhibitors," Bioinformation, vol. 11, no. 12, pp. 535-542, 2015.
49. N. A. Lunagariya, N. K. Patel, S. C. Jagtap, and K. K. Bhutani, "Inhibitors of pancreatic lipase: state of the art and clinical perspectives," EXCLI Journal, vol. 13, pp. 897-921, 2014.
50. K. Ninomiya, H. Matsuda, H. Shimoda et al., "Carnosic acid, a new class of lipid absorption inhibitor from sage," Bioorganic & Medicinal Chemistry Letters, vol. 14, no. 8, pp. 1943-1946, 2004.